Inventor
STENZEL WOLFGANG
DE28 patents
⚠️ This page may combine multiple inventors who share the name “STENZEL WOLFGANG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BEIERSDORF AG
12 patentsUS4409231AOct 11, 1983
Substituted aryloxyamino propanols, and process for their use
BEIERSDORF AG67 citations96
US4323570AApr 6, 1982
Substituted aminopyrimidines
BEIERSDORF AG81 citations94
US5028711AJul 2, 1991
Novel benzopyran derivatives, processes for their preparation and their use and preparations containing the compounds
BEIERSDORF AG24 citations92
US4801590AJan 31, 1989
Pyrido(1,8)naphthyridinones, and their use as pharmaceuticals
BEIERSDORF AG24 citations89
US4582834AApr 15, 1986
Substituted phenyl-2-(1H)-pyrimidinones useful for treating cardiac insufficiency in a warm-blooded organism
BEIERSDORF AG13 citations74
US5212186AMay 18, 1993
Cardioactive pyrrolobenzimidazoles
BEIERSDORF AG10 citations73
US5096914AMar 17, 1992
Novel benzopyran derivatives, processes for their preparation and their use and preparations containing the compounds
BEIERSDORF AG13 citations73
US4935414AJun 19, 1990
New indolylpropanols, processes for their preparation and their use, and preparations containing the compounds
BEIERSDORF AG11 citations71
US4952410AAug 28, 1990
Pharmaceutical products of moxonidine and hydrochlorothiazide
BEIERSDORF AG13 citations68
US5145849ASep 8, 1992
Indolylpropanols and preparations containing the compounds
BEIERSDORF AG2 citations62
US4434167AFeb 28, 1984
Pyrimidyl thioureas useful for the treatment of hypertension and hyperlipidemia
BEIERSDORF AG0 citations52
US4631281ADec 23, 1986
Substituted phenylpiperazinyl-propanols, a process for their preparation and their use, and formulations containing these compounds
BEIERSDORF AG0 citations49
LILLY CO ELI
9 patentsUS5545636AAug 13, 1996
Protein kinase C inhibitors
LILLY CO ELI110 citations94
US5672618ASep 30, 1997
Protein kinase C inhibitors
LILLY CO ELI26 citations92
US6693109B2Feb 17, 2004
Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation
LILLY CO ELI17 citations91
US6291469B1Sep 18, 2001
Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation
LILLY CO ELI39 citations91
US5731324AMar 24, 1998
Glycoprotein IIb/IIIa antagonists
LILLY CO ELI37 citations91
US6730792B2May 4, 2004
β3 adrenergic agonists
LILLY CO ELI21 citations90
US6410562B1Jun 25, 2002
Hypoglycemic imidazoline compounds
LILLY CO ELI19 citations83
US6448269B1Sep 10, 2002
Glycoprotein IIb/IIIa antagonists
LILLY CO ELI7 citations72
US6020362AFeb 1, 2000
Glycoprotein IIB IIIA antagonists
LILLY CO ELI6 citations72
BEIERSDORF LILLY GMBH
4 patentsUS5602137AFeb 11, 1997
Pyrimidine compounds and their use as pharmaceuticals
BEIERSDORF LILLY GMBH82 citations95
US5602136AFeb 11, 1997
Pyrimidine compounds and their use as pharmaceuticals
BEIERSDORF LILLY GMBH62 citations95
US5571813ANov 5, 1996
Fused pyrimidine compounds and their use as pharmaceuticals
BEIERSDORF LILLY GMBH74 citations95
US5843938ADec 1, 1998
Treatment of atherosclerosis
BEIERSDORF LILLY GMBH0 citations44